These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24486134)

  • 1. Substituted piperidines as HDM2 inhibitors.
    Ma Y; Lahue BR; Shipps GW; Brookes J; Wang Y
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1026-30. PubMed ID: 24486134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core modification of substituted piperidines as novel inhibitors of HDM2-p53 protein-protein interaction.
    Pan W; Lahue BR; Ma Y; Nair LG; Shipps GW; Wang Y; Doll R; Bogen SL
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1983-6. PubMed ID: 24656661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship study of 4-substituted piperidines at Leu26 moiety of novel p53-hDM2 inhibitors.
    Tian Y; Ma Y; Gibeau CR; Lahue BR; Shipps GW; Strickland C; Bogen SL
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2735-8. PubMed ID: 27080185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ordering of the N-terminus of human MDM2 by small molecule inhibitors.
    Michelsen K; Jordan JB; Lewis J; Long AM; Yang E; Rew Y; Zhou J; Yakowec P; Schnier PD; Huang X; Poppe L
    J Am Chem Soc; 2012 Oct; 134(41):17059-67. PubMed ID: 22991965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
    Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
    Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design and binding mode duality of MDM2-p53 inhibitors.
    Gonzalez-Lopez de Turiso F; Sun D; Rew Y; Bartberger MD; Beck HP; Canon J; Chen A; Chow D; Correll TL; Huang X; Julian LD; Kayser F; Lo MC; Long AM; McMinn D; Oliner JD; Osgood T; Powers JP; Saiki AY; Schneider S; Shaffer P; Xiao SH; Yakowec P; Yan X; Ye Q; Yu D; Zhao X; Zhou J; Medina JC; Olson SH
    J Med Chem; 2013 May; 56(10):4053-70. PubMed ID: 23597064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the p53/hdm2 protein-protein interaction-path to the clinic.
    Carry JC; Garcia-Echeverria C
    Bioorg Med Chem Lett; 2013 May; 23(9):2480-5. PubMed ID: 23541651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity.
    Leonard K; Marugan JJ; Raboisson P; Calvo R; Gushue JM; Koblish HK; Lattanze J; Zhao S; Cummings MD; Player MR; Maroney AC; Lu T
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3463-8. PubMed ID: 16647257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective synthesis and antioxidant activity of 3,4,5-substituted piperidine derivatives.
    Kim JH; Shyam PK; Kim MJ; Lee HJ; Lee JT; Jang HY
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3119-3121. PubMed ID: 27177825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenylpyrroles: Novel p53 activators.
    Gomha SM; Eldebss TM; Abdulla MM; Mayhoub AS
    Eur J Med Chem; 2014 Jul; 82():472-9. PubMed ID: 24934571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions.
    Lundholt BK; Heydorn A; Bjørn SP; Praestegaard M
    Assay Drug Dev Technol; 2006 Dec; 4(6):679-88. PubMed ID: 17199506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors.
    Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Kubo T; Kaneda M; Ohno H; Osada H; Fujii N
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3802-5. PubMed ID: 23726030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitors.
    Geng B; Comita-Prevoir J; Eyermann CJ; Reck F; Fisher S
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5432-5. PubMed ID: 21782427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
    Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
    Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
    J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(4):864-8. PubMed ID: 16298525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and SAR studies of a novel class of cytotoxic 1,4-disubstituted piperidines via Ugi reaction.
    de Castro S; Camarasa MJ; Balzarini J; Velázquez S
    Eur J Med Chem; 2014 Aug; 83():174-89. PubMed ID: 24956554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.